Osteopontin promotes survival of intestinal intraepithelial lymphocytes and protects against colitis

Intestinal intraepithelial lymphocytes (IEL) comprise a diverse population of cells that reside in the epithelium at the interface between the contents of the intestinal lumen and the sterile environment of the lamina propria. Because of this anatomical location, IEL are considered critical components of intestinal immune responses. Indeed, IEL are involved in many different immunological processes ranging from pathogen control to tissue stability. However, maintenance of IEL homeostasis is incompletely understood. In this report, we present evidence that osteopontin, a glycophosphoprotein with diverse roles in biomineralization, cell-mediated immunity, and inflammation, is important for maintaining normal levels of IEL. Mice in which the osteopontin gene (Spp-1) is disrupted present decreased levels of IEL subtypes, such as TCRαβ and TCRγδ IEL in the intestine, an effect not observed for lymphocytes in other immune compartments such as spleen or lamina propria, indicating an epithelium-specific effect. In vitro experiments show that mouse and human IEL survival is improved by culture with recombinant osteopontin. In vivo and in vitro IEL survival studies show that CD44, a ligand for osteopontin, is critical for the capacity of osteopontin to promote IEL survival. Adoptive transfer of total T cells (including Tregs) from wild type mice into Spp-1−/−Rag-2−/− mice results in the development of exacerbated intestinal inflammation, as compared with Rag-2−/− recipient mice. Further analyses show that osteopontin-deficiency results in decreased survival of Foxp3-expressing T cells. These findings support osteopontin’s critical role in IEL homeostasis and make it a potential target for curbing intestinal inflammation.

The impact of the TRPM2 ion channel on inflammation and macrophage metabolism in gastrointestinal models

Macrophages can play a vital role in regulating pro-inflammatory pathways that drive chronic inflammation and impact carcinogenesis. We previously published that TRPM2 regulates ROS production and the pro-inflammatory cytokine profile of macrophages in vivo and in vitro in H. pylori infection models. Since macrophage function and activation profiles can be regulated by metabolism, the impact of the TRPM2 channel on macrophage metabolism was assessed using bone marrow derived macrophages in Seahorse Extracellular Flux Assays and Mitotracker assays. The data demonstrated an unfavorable shift in mitochondrial content in Trpm2−/− macrophages after M1 activation. Consistent with this shift, the oxygen consumption rate was reduced in Trpm2−/− macrophages compared to WT macrophages, and the extracellular acidification rate at baseline and glycolytic reserve were higher in Trpm2−/− macrophages following classical activation. To investigate the role of TRPM2 in controlling other gastrointestinal pathologies, including acute colitis and carcinogenesis, the dextran sulfate sodium (DSS) colitis model and the azoxymethane (AOM)/DSS colitis-associated cancer (CAC) model were used. Trpm2−/− mice were not protected against acute DSS-induced colitis. Our endpoint analysis in the CAC model demonstrated that Trpm2−/− mice developed more numerous but smaller tumors than WT mice and immunohistological analysis suggests a shift in numbers of innate cells in the Trpm2−/− tumors compared to WT tumors. In the non-tumor areas, the histological injury score was reduced in the Trpm2−/− mice compared to WT mice. These data suggest that TRPM2 regulates Mϕ metabolism and impacts inflammation in the gastrointestinal tract.

Osteopontin provides a survival signal for intestinal intraepithelial lymphocytes in mice

Intraepithelial lymphocytes (IEL) are a diverse immune population residing in between intestinal epithelial cells, which possess important roles during mucosal immune responses. The IEL family comprises cells such as TCRαb+CD4+, TCRαb+CD8+, TCRgd+, TCRab+CD8aa+, iCD8a and iCD3+, among others. Osteopontin (OPN), a pleiotropic cytokine encoded by the Spp-1 gene, is well known for its function in tissue remodeling, modulation of Th1 responses development, maintenance of Th17 function, and homeostasis of NK cells. Herein, we investigated the impact of OPN in the IEL compartment.

We compared the cell numbers of IEL, lamina propria (LP) lymphocytes and splenocytes from Spp-1−/− and wild-type (WT) mice. OPN deficiency reduced the number of TCRγδ+, TCRβ+CD4+, TCRβ+CD8α+ and TCRβ+CD4+CD8α+ IEL, but had no effect on LP and spleen lymphocytes. In in vitro studies, IEL from WT mice cultured in the presence of rOPN showed better survival rates than IEL incubated alone. The increased survival was blunted to control levels when CD44, a receptor for OPN, was blocked with anti-CD44 antibody.

When total T cells (including Tregs) from WT splenocytes were transferred into Spp-1−/−Rag-2−/− and Rag2−/− mice, we observed that although OPN deficiency did not affect donor-derived IEL reconstitution at day 7 post-transfer, it decreased the number of CD4+ and CD4+CD8α+ IEL at day 28 post-transfer. As expected, Rag-2−/− mice remained healthy throught the experiment; however, Spp-1−/−Rag-2−/− recipient mice presented a remarkably loss of body weight and colon inflammation.

Together, our results indicate that OPN is a critical survival signal for IEL via CD44, and that OPN-deficiency promotes development of colitis even in the presence of Tregs.

Mitochondrial protein Fus1/Tusc2 in premature aging and age-related pathologies: critical roles of calcium and energy homeostasis

Decreased energy production and increased oxidative stress are considered to be major contributors to aging and aging-associated pathologies. The role of mitochondrial calcium homeostasis has also been highlighted as an important factor affecting different pathological conditions. Here, we present evidence that loss of a small mitochondrial protein Fus1 that maintains mitochondrial homeostasis results in premature aging, aging-associated pathologies, and decreased survival. We showed that Fus1KO mice develop multiple early aging signs including lordokyphosis, lack of vigor, inability to accumulate fat, reduced ability to tolerate stress, and premature death. Other prominent pathological changes included low sperm counts, compromised ability of adult stem cells to repopulate tissues, and chronic inflammation. At the molecular level, we demonstrated that mitochondria of Fus1 KO cells have low reserve respiratory capacity (the ability to produce extra energy during sudden energy demanding situations), and show significantly altered dynamics of cellular calcium response.

Our recent studies on early hearing and memory loss in Fus1 KO mice combined with the new data presented here suggest that calcium and energy homeostasis controlled by Fus1 may be at the core of its aging-regulating activities. Thus, Fus1 protein and Fus1-dependent pathways and processes may represent new tools and targets for anti-aging strategies.

The thymus leukemia antigen controls intraepithelial lymphocyte function and inflammatory bowel disease (39.53)

Intestinal intraepithelial lymphocytes (IEL) bear a partially activated phenotype that permits them to rapidly respond to antigenic insults. However, this phenotype also implies that IEL must be highly controlled to prevent misdirected immune reactions. It has been suggested that IEL are regulated through the interaction of the CD8alpha-alpha homodimer with the thymus leukemia (TL) antigen expressed by intestinal epithelial cells. We have generated and characterized mice genetically deficient in TL expression. Our findings show that TL expression plays a critical role in maintaining IEL effector functions. Moreover, TL deficiency accelerated colitis in a genetic model of inflammatory bowel disease. These findings reveal an important regulatory role of TL in controlling IEL function and intestinal inflammation.

Detection of Trypanosoma cruzi with the polymerase chain reaction and in situ hybridization in infected murine cardiac tissue

Chagas' disease is caused by the hemoflagellate protozoan Trypanosoma cruzi, which is predominantly found in South and Central America and Mexico. Although the parasite is present in the United States, confirmed cases of human disease are rare. The most serious manifestation of chronic Chagas' disease is a progressive inflammatory cardiomyopathy. However, T. cruzi has not been consistently demonstrated with histologic techniques in inflammatory cardiac lesions. In this study, we used both polymerase chain reaction (PCR) amplification of extracted DNA from hematoxylin and eosin-stained tissue scrapings, and in situ hybridization to detect the presence of T. cruzi in infected murine cardiac tissue sections. Three T. cruzi-specific DNA sequences were used: a 122-basepair (bp) sequence localized within the minicircle network (MCS), a 188-bp nuclear repetitive sequence (RS), and a 177-bp sequence within the open reading frame of a gene coding for a flagellar protein (FPS). We found that all three sequences are amplifiable from scrapings of murine cardiac tissue. The MCS and RS are detected at 0.167 and 0.24 amastigote DNA equivalents, while FPS is barely detected at 0.24 amastigote DNA equivalents. On the other hand, in situ hybridization with all three sequences allowed for the detection of T. cruzi amastigotes within the tissue. The MCS and FPS, however, consistently yielded a more intense signal. These results indicate that PCR and in situ hybridization may prove useful in establishing the prevalence of T. cruzi in human chagasic cardiomyopathy.